Abstract
Purposes
Sentinel node identification using indocyanine green (ICG) is not only simpler, but also more cost-effective, than using radioisotope tracers. We herein examined the utility and pitfalls of sentinel node (SN) identification using ICG during segmentectomy in patients with cT1N0M0 non-small cell lung cancer (NSCLC).
Methods
ICG was injected around the tumor after thoracotomy, followed by segmentectomy and lymph node dissection, in 135 patients with cT1N0M0 NSCLC. The dissected nodes were examined using an ICG fluorescence imaging system.
Results
SNs could be identified in 113 patients (84 %). The mean number of SNs was 2.3 ± 1.3. The percentages of being an SN were 57 % for both stations #12 and #13, which was significantly higher than the 18 % for #10 and 22 % for #11 (p < 0.001). Fourteen patients had N1 or N2 disease. Of these, the SNs were true positive (i.e., SNs contained metastasis) in 11 patients (79 %) and false negative (i.e., SNs did not contain metastasis, while non-SNs contained metastasis) in three patients (21 %). Of the three patients with false-negative results, all non-SNs containing metastases were at station #12 or #13.
Conclusion
While ICG makes it simple to identify SNs during segmentectomy for cT1N0M0 NSCLC, stations #12 and #13 should be submitted for frozen sections along with the identified SNs to avoid missing true SNs.
Similar content being viewed by others
References
Nomori H, Okada M. Illustrated textbook of anatomical pulmonary segmentectomy. Berlin: Springer; 2012.
Koike T, Yamato Y, Yoshiya K, Shimoyama T, Suzuki R. Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg. 2003;125(4):924–8.
Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg. 2006;132:769–75.
Nomori H, Mori T, Ikeda K, Yoshimoto K, Iyama K. Segmentectomy for cT1N0M0 non-small cell lung cancer: a prospective study at a single institute. J Thorac Cardiovasc Surg. 2012;144:87–93.
Minamiya Y, Saito H, Motoyama S, Sato Y, Ito A, Yoshino K, et al. Diagnostic imaging in the preoperative management of lung cancer. Surg Today. 2014;44:1197–206.
Mazza F, Ferrari E, Mainer P, Dozin B, Rotto GB. Pleural lavage cytology predicts recurrence and survival, even in early non-small cell lung cancer. Surg Today. 2015;45:322–8.
Liptay MJ, Masters GA, Winchester DJ, Edelman BL, Carrido BJ, Hirshctritt TR, Perlman RM, Fly WAF. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg. 2000;70:384–90.
Nomori H, Horio H, Naruke T, Orikasa H, Yamazaki K, Suemasu K. Use of technetium-99 m tin colloid for sentinel lymph node identification in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2001;124:486–92.
Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K. In vivo identification of sentinel lymph nodes for clinical stage I non-small cell lung cancer for abbreviation of mediastinal lymph node dissection. Lung Cancer. 2004;46:49–55.
Nomori H, Ikeda K, Mori T, Shiraishi S, Kobayashi H, Iwatani K, Kawanaka K, Kobayashi T. Sentinel node identification in clinical stage Ia non-small cell lung cancer by a combined single photon emission computed tomography/computed tomography system. J Thorac Cardiovasc Surg. 2007;134:182–7.
Nomori H, Ohba Y, Yoshimoto K, Shibata H, Mori T, Shiraishi S, Kawanaka K, Kobayashi T. Difference of sentinel lymph node identification between tin colloid and phytate in patients with non-small cell lung cancer. Ann Thorac Surg. 2009;87:906–10.
Nomori H. Sentinel node mapping in lung cancer. The Japanese experience. Semin Thorac Cardiovasc Surg. 2009;21:316–22.
Nomori H, Ohba Y, Shibata H, Shiraishi K, Mori T, Shiraishi S. Required area of lymph node sampling during segmentectomy for clinical stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2010;139:38–42.
Miyashiro I, Miyoshi N, Hiratsuka M, Kishi K, Yamada T, Obue M, et al. Detection of sentinel node in gastric cancer surgery by indocyanine green fluorescence imaging: comparison with infrared imaging. Ann Surg Oncol. 2008;15:1640–3.
Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005;12:211–5.
Tsujino Y, Mizumoto K, Matsuzaka Y, Niihara H, Morita E. Fluorescence navigation with indocyanine green for detecting sentinel nodes in extramammary Paget’s disease and squamous cell carcinoma. J Dermatol. 2009;36:90–4.
Yamashita S, Tokuishi K, Anami K, Miyawaki M, Moroga T, Kamei M, et al. Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2011;141:141–4.
Oh Y, Quan YH, Choi Y, Kim CK, Kim H, Kim HK, Kim BM. Intraoperative combined color and fluorescent images-based sentinel node mapping in the porcine lung: comparison of indocyanine green with or without albumin premixing. J Thorac Cardiovasc Surg. 2013;146:1509–15.
Gilmore DM, Khullar OV, Jaklitsch MT, Chirieac LR, Frangioni JV, Colson YL. Identification of metastatic nodal disease in phase 1 dose-escalation trial of intraoperative sentinel lymph node mapping in non-small cell lung cancer using near-infrared imaging. Thorac Cardiovasc Surg. 2013;146:569–70.
Staging Manual in Thoracic Oncology. Peter Goldstraw, FRCS, Executive Editor. International Association for the Study of Lung Cancer. 2009.
Naruke T, Tsuchiya R, Kondo H, Nakayama H, Asamura H. Lymph node sampling in lung cancer: how should it be done? Eur J Cardiothorac Surg. 1999;16:S17–24.
Kim HK, Kim SE, Park JJ, Jeon MJ, Mok YJ, Choi YH. Sentinel node identification using technetium-99 m neomannosyl human serum albumin in esophageal cancer. Ann Thorac Surg. 2011;91:1517–22.
Kim S, Kim HK, Kang DY, Jeong JM, Choi YH. Intra-operative sentinel lymph node identification using a novel receptor-binding agent (technetium-99m neomannosyl serum albumin, 99mTc-MSA) in stage I non-small cell lung cancer. Eur J Cardio Thorac Surg. 2010;37:1450–6.
Ballardini B, Santoro L, Sangalli C, Gentilini O, Renne G, Lissidini G, et al. The indocyanine green method is equivalent to the 99mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: a concordance and validation study. Eur J Surg Oncol. 2013;39:1332–6.
Polom K, Murawa D, Nowaczyk P, Rho YS, Murawa P. Breast cancer sentinel lymph node mapping using near infrared guided indocyanine green and indocyanine green–human serum albumin in comparison with gamma emitting radioactive colloid tracer. Eur J Surg Oncol. 2012;38:137–42.
Samorani D, Fogacci T, Panzini I, Frisoni G, Accardi FG, Ricci M, Fabbri E, Nicoletti S, Flenghi L, Tamburini E, Tassinari D, Gianni L. The use of indocyanine green to detect sentinel nodes in breast cancer: a prospective study. Eur J Surg Oncol. 2015;41:64–70.
Nomori H, Ikeda K, Mori T, Kobayashi H, Iwatani K, Kawanaka K, Shiraishi S, Kobayashi T. Sentinel node navigation segmentectomy for c-T1N0M0 non-small cell lung cancer. J Thorac Cardiovasc Surg. 2007;133:780–5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests
The authors have no conflicts of interest or financial ties to disclose.
Rights and permissions
About this article
Cite this article
Nomori, H., Cong, Y. & Sugimura, H. Utility and pitfalls of sentinel node identification using indocyanine green during segmentectomy for cT1N0M0 non-small cell lung cancer. Surg Today 46, 908–913 (2016). https://doi.org/10.1007/s00595-015-1248-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-015-1248-6